Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders (ENHANCE)
Delirium, Neurocognitive Disorders, Mild Cognitive Impairment
About this trial
This is an interventional prevention trial for Delirium focused on measuring Delirium, Clinical Trial, Comparative Effectiveness Research, Implementation Science
Eligibility Criteria
Inclusion Criteria: Provision of informed consent At least 70 years of age Anticipated length of hospital stay at least 72 hours Family member or care partner available to be on-site in the hospital At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment) Exclusion Criteria: Delirium on admission Unable to communicate verbally (e.g., coma, mechanical ventilation) Unable to participate fully in interventions (e.g., terminal condition, advanced dementia) Staff safety concerns (e.g., violent behavior) Cardiac or intracranial surgery (due to competing causes of delirium)
Sites / Locations
- Saddleback Medical Center
- MaineHealth
- Michigan Medicine
- Hospital of the University of Pennsylvania
- Allegheny General Hospital
- University of Utah
- Meriter Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Hospital Elder Life Program (HELP)
Family-Augmented Hospital Elder Life Program (FAM-HELP)
Hospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization.
The FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols.